Cargando…
Risk factors and prognostic significance of lateral pelvic lymph node dissection after neoadjuvant chemoradiotherapy for rectal patients with clinically suspected lateral lymph node metastasis
AIM: It is still controversial whether the addition of lateral pelvic lymph node (LPN) dissection (LPND) to total mesorectal excision (TME) can provide a survival benefit after neoadjuvant chemoradiotherapy (nCRT) in rectal cancer patients with pathological lateral lymph node metastasis (LPNM). METH...
Autores principales: | Zhou, Sicheng, Jiang, Yujuan, Pei, Wei, Liang, Jianwei, Zhou, Zhixiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8714447/ https://www.ncbi.nlm.nih.gov/pubmed/34961494 http://dx.doi.org/10.1186/s12893-021-01443-5 |
Ejemplares similares
-
Prognostic significance of lateral pelvic lymph node dissection for middle-low rectal cancer patients with lateral pelvic lymph node metastasis: a propensity score matching study
por: Zhou, Sicheng, et al.
Publicado: (2022) -
Does neoadjuvant chemoradiotherapy increase the effect of lateral lymph node dissection on urogenital function?
por: Jiang, Yujuan, et al.
Publicado: (2022) -
Mesorectal excision with lateral lymph node dissection for mid-low rectal cancer with lateral lymph node metastasis: efficacy and prognostic analysis
por: Zhou, Sicheng, et al.
Publicado: (2022) -
Optimization of therapeutic strategies for selective lateral lymph node dissection after neoadjuvant chemoradiotherapy in patients with rectal cancer with clinical suspected lateral lymph node metastasis
por: Liu, Yuan, et al.
Publicado: (2023) -
Oncologic Benefit of Adjuvant Therapy in Lateral Pelvic Lymph Node Metastasis following Neoadjuvant Chemoradiotherapy and Lateral Pelvic Lymph Node Dissection
por: Jiang, Yu-Juan, et al.
Publicado: (2022)